Efficacy and safety of omalizumab therapy in urticaria vasculitis

Authors: Fiorella Petrelli, Daiana Giannini, Silvia Bilia, Isabella Del Corso, Valeria Rocchi, Paola Migliorini, Ilaria Puxeddu

Source: Frontiers in Allergy, Vol 3 (2022)

Subject Terms: urticarial vasculitis, omalizumab, anti IgE, therapy, biological agent, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/falgy.2022.952079/full; https://doaj.org/toc/2673-6101

Access URL: https://doaj.org/article/a8c3f71312d743c89012a5d82e307541

Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis?

Authors: Barsotti, Simone, d'Ascanio, Anna, Valentina, Venturini, Chiara, Stagnaro, Silvia, Bilia, Laura, Amanzi, Mosca, Marta, Della Rossa, Alessandra

Source: Clinical rheumatology. 39(1):69-75

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100126329438.0x000001&indx=1&recIds=ETOCvdc_100126329438.0x000001

Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis?

Authors: Barsotti, Simone, d'Ascanio, Anna, Valentina, Venturini, Chiara, Stagnaro, Silvia, Bilia, Laura, Amanzi, Mosca, Marta, Della Rossa, Alessandra

Source: Clinical Rheumatology; Jan2020, Vol. 39 Issue 1, p69-75, 7p, 1 Diagram, 3 Charts, 1 Graph

Subject Terms: SPECKLE interference, SYSTEMIC scleroderma, ULCERS, SKIN diseases, BLOOD flow